1. Evaluating Performance of Regression and Classification Models Using Known Lung Carcinomas Prognostic Markers
    Shrikant Pawar et al, 2022, Bioinformatics and Biomedical Engineering CrossRef
  2. A hybrid deep forest-based method for predicting synergistic drug combinations
    Lianlian Wu et al, 2023, Cell Reports Methods CrossRef
  3. A Systematic Study of Traditional Chinese Medicine for the Treatment of Lung Adenocarcinoma Using a Reverse Network of Key Targets Based on Bioinformatics and Molecular Docking: Curcumin and Trans-Resveratrol as Potential Drug Candidates for Lung Adenocarcinoma
    Wujun Wang et al, 2023, Natural Product Communications CrossRef
  4. Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins
    Ilana B. Kotliar et al, 2023, Pharmacological Reviews CrossRef
  5. Large-Scale Two-Sample Comparison of Support Sets
    Haoyu Geng et al, 2023, Journal of the American Statistical Association CrossRef
  6. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
    Dan Luo et al, 2023, Breast Cancer Research CrossRef
  7. Prognostic significance of AP-2α/γ targets as cancer therapeutics
    Damian Kołat et al, 2022, Scientific Reports CrossRef
  8. Serum lncRNA RAMP2-AS1 Served as a Biomarker of Deep Vein Thrombosis Occurrence and Development in Elderly
    Hailong Zhang et al, 2024, Indian Journal of Hematology and Blood Transfusion CrossRef
  9. RAMP2-AS1 inhibits CXCL11 expression to suppress malignant phenotype of breast cancer by recruiting DNMT1 and DNMT3B
    Li Li et al, 2022, Experimental Cell Research CrossRef
  10. Two-Way Truncated Linear Regression Models with Extremely Thresholding Penalization
    Hao Yang Teng et al, 2022, Journal of the American Statistical Association CrossRef